Home › Markets › Health Care › USPH

U.S. Physical Therapy Inc. (USPH)

USPH trades on NYSE in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$85.44
-0.57% on the day
Market cap
$1.3B
Small cap
Revenue · 2025
$781.0M
+16.3% on 2024
Net income · 2025
$39.6M
5.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerUSPH on NYSE
SectorHealth Care
IndustryMedical/Nursing Services
CountryUnited States
IPO year1992
SEC CIK0000885978
SEC industry codeServices-Health Services
Incorporated inNV

Financials · 2025

LineValue
Revenue$781.0M
Net income$39.6M
Operating income$86.7M
Net margin5.1%
Operating margin11.1%
Revenue growth+16.3%
Cash$35.6M
Total assets$1.2B
P/E (computed)32.2×
P/S (computed)1.6×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52023-05-25
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-08-07
Latest current report8-K2026-09-28
Latest proxyDEF 14A2026-04-16

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.1%
1 month+4.6%
3 months+15.2%
Year to date+9.5%
1 year-3.6%
From 52-week high-8.2%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Nursing Services

TickerCompanyPriceDayMarket cap
INNVInnovAge Holding Corp.$9.02-1.42%$1.2B
PNTGThe Pennant Group Inc. Common Stock$40.15-0.91%$1.4B
OMDAOmada Health Inc.$18.30-16.32%$1.1B
TDOCTeladoc Health Inc.$6.00+1.35%$1.1B
AHCOAdaptHealth Corp.$6.33+3.09%$863.1M
WGSGeneDx Holdings Corp.$64.96+1.79%$1.9B
ADUSAddus HomeCare Corporation$114.53-0.82%$2.1B
STLNStarling Oncology Inc.$6.70-3.18%$682.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier